Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|June 10, 2026
Conservative Oxygen for Unresponsive Patients after Cardiac Arrest, Carol L Hodgson, Diane Mackle, et al.
The Lancet. Respiratory Medicine|September 29, 2022
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Circulation. Heart Failure|April 29, 2025
Long-Term Functional Outcomes in the First 12 Months After VA-ECMO in Adult Patients: A Prospective, Multicenter StudyAry Serpa Neto, Alisa M Higgins, Michael J Bailey, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|January 9, 2025
Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 monthsAtacan D Ertugrul, Ary Serpa Neto, Bentley J Fulcher, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Critical Care (London, England)|November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
American Journal of Respiratory and Critical Care Medicine|March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical IllnessCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Pageof 13